Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.
- DOI
- 10.1016/j.jaad.2021.09.050
- Published
- 2022 Feb
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2021.09.050,
title = {Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.},
author = {Bettuzzi T and Drucker A and Staumont-Sallé D and Bihan K and Lebrun-Vignes B and Sbidian E},
year = {2022},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2021.09.050},
url = {https://doi.org/10.1016/j.jaad.2021.09.050}
}RIS
TY - JOUR TI - Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database. AU - Bettuzzi T AU - Drucker A AU - Staumont-Sallé D AU - Bihan K AU - Lebrun-Vignes B AU - Sbidian E PY - 2022 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2021.09.050 UR - https://doi.org/10.1016/j.jaad.2021.09.050 ER -
APA
T, B., A, D., D, S., K, B., B, L., & E, S. (2022). Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2021.09.050
Source records
- pubmed · retrieved 2026-11-10T14:39:50.648Z